- •Surgical Management of Inflammatory Eye Disease
- •Foreword
- •Preface
- •Contents
- •Contributors
- •I Invasive Drug Delivery
- •1 Injectable Intraocular Corticosteroids
- •2 Intraocular Corticosteroid Implants
- •II Surgery to Modify Uveitic Activity
- •I Anterior Segment
- •6 Surgery for Band Keratopathy
- •8 Perioperative Medical Management
- •9 Pars Plana Lensectomy
- •14 Cataract Surgery in Childhood Uveitis
- •17 Cyclodestructive Procedures
- •II Posterior Segment
- •24 Diagnostic Vitrectomy
- •25 Choroidal Biopsy
- •26 Retinal Biopsy
- •Subject Index
Subject Index
5-fluoroudine (5-Furd) 28
5-fluorouracil (5-FU) 27, 28, 71, 151, 156, 206 5-Fluorouracil, 5-Fluorouridine, Mitomycin, Taxol,
Daunorubicin, EDTA and FGF-Saporin 27 5-FU 27, 28
γ-globulin 129
A
ab interno laser sclerostomy 70 ab interno retinal biopsy 253 ablation 214
ACE (angiotensin-converting enzyme) 64 acetazolamide 51, 77, 133, 142, 143
acquired immunodeficiency syndrome (AIDS) 208 acrylic IOLs 137
active antiretroviral therapy (HAART) 244 acute retinal hemorrhagic retinal vasculitis 193 acute retinal necrosis (ARN) 85, 207, 249
acute retinal necrosis syndrome (ARNS) 89, 90, 230,
241 |
|
99, 229, 243 |
|
|
|
acyclovir |
|
|
|
||
after cataract |
132, 140 |
|
|
||
Ahmed |
152 |
|
|
|
|
Ahmed glaucoma valve 152, 157 |
|
||||
AIDS 192, 229, 242 |
|
|
|||
air vitrectomy |
245 |
|
|
||
albumin |
129 |
|
150 |
|
|
alpha adrenoreceptor agonists |
|
||||
amblyopia |
72, 128, 130, 132, 135, 143, 144 |
||||
amniotic membrane graft 168 |
|
64 |
|||
amniotic membrane transplantation |
|||||
Amphotericin B 241, 242 |
|
|
|||
Amsler’s sign |
98, 123 |
|
|
||
Amsler tests |
143 |
|
|
||
anesthesia |
75 |
|
|
||
angiographic |
187 |
|
|
||
angiography |
42, 94 |
81 |
|
||
angiotensin converting enzyme |
120, 129, 141 |
||||
anterior capsule opacification (ACO) |
|||||
anterior capsule tears 97
anterior chamber-associated immune deviation (ACAID) 36
anterior chamber depth 94 anterior chamber paracentesis 9 anterior chamber puncture 222
anterior hyaloid membrane 134 anterior vitrectomy 128, 134, 141 anti-angiogenic factors 186 anti-vascular endothelial growth factor
(anti-VEGF) 6 antibiotic 76 antibody 221
anticoagulant therapy 194 antigen-presenting cells (APC) 36 antigens 36
antiproliferative agents 27 antiviral drug resistance 229 ants’ eggs 48
APC 36 aphakia 105, 152
aphakic contact lenses 128 apraclonidine 150
arcus senilis 160
argon laser peripheral iridoplasty 116 argon laser photocoagulation 194
associated surgery |
73 |
atrophy of the iris |
73 |
autologous conjunctival-limbal transplantation 233 autologous conjunctiva transplantation 168
Avastin (bevacizumab) |
160 |
|
||
Azathioprine 51, 194 |
|
|
|
|
B |
|
|
50, 214 |
|
B-Scan ultrasonography |
|
|||
BAB 119, 120 |
129 |
|
|
|
BAB breakdown |
|
|
|
|
Baerveldt 152 |
|
|
|
158 |
Baerveldt glaucoma drainage device |
||||
Baerveldt glaucoma drainage implant |
157 |
|||
balanced salt solution (BSS) 64 |
|
|||
bandage contact lens |
65 |
|
||
band keratopathy |
50, 63, 68, 70, 138, 139, 144, 160 |
|||
Beehler pupil dilator |
96 |
|
|
|
Behçet’s disease (BD) 12, 39, 40, 42, 43, 82, 110, 192
– intravitreal TA 12
best corrected visual acuity 41 beta-blocking agents 142 bevacizumab 143 bevacizumab (Avastin®) 124
binocular indirect ophthalmoscopy (BIO) 39
260 |
Subject Index |
|
biocompatibility 103, 104, 129 biodegradable dexamethasone implant 21 biopsy 229
birdshot chorioretinopathy 185, 186 birdshot retinochoroidopathy 11, 231 blebitis 157
bleb leaks 71
blood-retinal barrier (BRB) 24, 36, 192
–inner blood–retinal barrier 7
–outer blood–retinal barrier 7
blood–aqueous barrier (BAB) |
69, 82, 95, 104, 109, |
|||
119, 129, 138 |
|
|
|
|
blood–aqueous barrier breakdown 94 |
||||
borreliosis 229 |
|
|
|
|
brimonidine |
142, 150 |
|
||
brinzolamide |
142 |
163 |
|
|
Brown syndrome |
|
|||
C |
73 |
|
|
|
campimetry |
|
133 |
|
|
can-opener technique |
|
|||
candida 35 |
129 |
|
|
|
capsular bag |
|
|
|
|
capsular bending rings 141 |
|
|||
capsular biocompatibility 130 |
|
|||
capsular contraction |
120 |
122 |
||
capsular contraction syndrome |
||||
capsular dislocation |
122 |
|
||
capsular fibrosis 141 |
68 |
|
||
capsular opacification |
|
|||
capsular response |
121 |
|
||
capsular retraction |
129 |
|
||
capsular rim tears |
75 |
|
||
capsular tension ring |
98, 250 |
|
||
capsulectomy |
71, 88, 138 |
|
||
capsule shrinkage |
134 |
|
||
capsulorhexis |
75, 93, 106 |
|
||
capsulotomy |
88, 121 |
|
|
|
carcinoma in situ of the conjunctiva and cornea 233
cat-scratch disease 192 |
|
||||
cataract |
9, 50, 67, 87, 88, 94, 99, 119, 144 |
||||
cataract surgery |
68, 73, 81 |
|
|||
ceftazidime |
241 |
|
|
|
|
cefuroxime |
76 |
|
|
9 |
|
central retinal artery occlusion (CRAO) |
|||||
central retinal vein occlusion (CRVO) 8 |
9 |
||||
central serous chorioretinopathy (CSCR) |
|||||
chelation with EDTA |
64, 138 |
|
|||
chest X-ray |
81 |
127 |
|
|
|
childhood uveitis |
|
|
|||
cholinergic drugs |
69 |
|
|
||
chorioretinitis 94 |
|
|
|||
choroidal biopsy |
249 |
214 |
|
||
choroidal detachment |
|
||||
choroidal folds |
142 |
|
229 |
|
|
||||
choroidal granuloma |
|
|
|||||||
choroidal neovascularization (CNV) 6, 12, 185 |
|||||||||
– intravitreal TA |
8 |
|
|
|
|
||||
choroidal swelling |
82 |
|
8 |
||||||
chronic open-angle glaucoma (COAG) |
|||||||||
chronic suppurative otitis media. see CSOM |
|||||||||
cidofovir |
214, 243 |
|
|
|
|
||||
ciliary body |
214 |
|
|
214 |
|
|
|||
ciliary body ablation |
|
|
|
||||||
ciliary body failure |
115, 116, 214 |
|
|||||||
ciliary body traction |
|
214 |
|
|
|||||
ciliary body traction detachment 215 |
|
||||||||
ciliary traction membranes |
142 |
|
|||||||
Cionni rings |
122 |
|
|
|
|
|
|||
ciprofloxacin |
28 |
|
|
|
99 |
|
|||
circumlinear capsulorhexis |
|
||||||||
cis-4-hydroxyproline (CHP) |
28 |
|
|||||||
cleansing |
120 |
|
|
|
|
|
|
||
CME |
7, 11, 40, 42, 43, 47, 48, 49, 50, 54, 69, 70, 77, |
||||||||
82, 83, 130, 133, 135, 142, 144 |
|
||||||||
– pseudophakic |
11 |
|
|
|
|||||
CMV retinitis |
89 |
|
76 |
|
|
||||
coagulation cascade |
|
|
|||||||
coagulation factors |
129 |
|
|
||||||
Coats’ disease |
10 |
|
|
54 |
|
|
|||
coaxial illumination |
|
|
|
||||||
cocoon 134 |
|
|
|
|
|
|
|
||
collagen |
151 |
38 |
|
|
|
|
|||
collagen fibrils |
|
|
|
|
|||||
collagen IV |
137 |
|
|
|
|
|
|||
color tests |
72 |
|
|
|
|
|
|
||
combination |
168 |
|
|
77, 129, 193 |
|
||||
complement cascade |
|
|
|||||||
complement system |
76 |
|
|
||||||
confocal microscopy |
|
228 |
|
|
|||||
confocal scanning laser 187 |
|
|
|||||||
congenital hereditary endothelial dystrophy 63 |
|||||||||
conjunctival autograft |
228 |
|
|
||||||
contact lens |
90, 132, 135, 144 |
|
|||||||
continuous circular capsulorhexis (CCC) 75 |
|||||||||
continuous curvilinear capsulorhexis |
133 |
||||||||
core vitrectomy |
186 |
|
|
|
|||||
corneal abscess |
228 |
|
|
|
|
||||
corneal endothelial guttae 70 |
|
||||||||
corneal opacities |
94 |
|
115 |
|
|||||
corneal specular microscopy |
|
||||||||
corticosteroid |
5, 40, 51, 83, 95, 142, 156 |
||||||||
–intravitreal concentration 6
–intravitreal corticosteroid injection 5
–mechanism 7
cotton wool spots 192 COX-2 inhibitors 27 crescent knife 228
Crohn’s disease |
193 |
|
cryocoagulation |
124 |
|
cryotherapy |
47, 195, 204 |
|
crystallins |
129 |
|
CsA 28, 42 |
|
|
culture 240
culture of vitreous samples 240
cyclitic membrane |
48, 50, 69, 71, 86, 115, 116, 134, |
||
138, 203 |
|
|
71 |
cyclitic membrane formation |
|||
cycloablation therapy |
70 |
|
|
cyclodestruction 152 |
|
156, 157, 176 |
|
cyclodestructive procedures |
|||
cyclodialysis cleft |
214 |
|
|
cyclodialysis spatula 160 |
|
||
cyclophosphamide |
231 |
|
|
cyclophotocoagulation |
157 |
|
|
cyclosporine A (CsA) |
28, 41, 194 |
||
cystoid macula edema |
144 |
|
|
cystoid macular edema (CME) 10, 68, 81, 93, 97, 104, 123, 130, 143, 185, 186
–“pseudophakic” CME 11
–refractory macular edema 6 cystotome 134
cytokine 36, 37, 39 cytokine assays 223 cytology 223
cytomegalovirus (CMV) retinitis 8, 85, 185, 208, 241 |
||
D |
151, 228 |
|
deep sclerectomy |
||
delayed hypersensitivity |
36 |
|
Descemet’s membrane |
114 |
|
detachment 47 |
6, 28, 78, 82, 88, 97, 133 |
|
dexamethasone |
||
– intravitreal dexamethasone |
13 |
||
dexamethasone sustained delivery device |
|||
(DEX-BDD, Posurdex™) 7 |
186 |
||
diabetic macular edema (DME) |
|||
diclofenac 65, 78 |
|
|
|
dorzolamide |
142 |
|
|
doxorubicin |
28 |
152 |
|
drainage devices |
|
||
E |
12, 43, 192, 194, 203, 209 |
||
Eales disease |
|||
– intravitreal TA |
12 |
|
|
Early Treatment Diabetic Retinopathy Study |
|||
(ETDRS) |
11 |
|
|
echothiophate 160
EDTA (Ethylene diamine tetraacetic acid) chelation 64
either imipenem 240 electrophysiological test 131, 132
Subject Index |
|
|
261 |
|
electroretinography |
42 |
|||
electrotransfer |
26 |
|
||
Elschnig pearl |
134 |
|
||
Elschnig pearl formation 121 |
||||
Elvax disc |
27 |
|
157 |
|
endocycloablation |
||||
endodiathermy |
250 |
|
||
endolaser |
250 |
|
|
|
endolaser photocoagulation 54 |
||||
endophotocoagulation 195 |
||||
endophotocoagulator |
157 |
|||
endophthalmitis |
28, 151, 157, 209, 222, 230, 238, 239, |
|||
241 |
|
|
|
|
–infectious endophthalmitis following intravitreal injection of TA 8
–intravitreal corticosteroids in the treatment of infectious endophthalmitis 13
–sterile inflammatory reaction 6
endoresection of choroidal melanomas 249
endotoxin-induced uveitis (EIU) model |
30 |
|||||||
enlarged sclerotomy |
250 |
|
|
|||||
enucleation |
|
228 |
135 |
|
|
|
||
epikeratophakia |
|
|
|
|
||||
epinephrine |
138 |
|
|
|
37, 38, 68, 77, 94, 135, |
|||
epiretinal membrane (ERM) |
||||||||
185, 186, 194 |
|
233 |
|
|
|
|||
episcleral nodules |
|
|
|
|||||
epitheloid |
129 |
120 |
|
|
|
|||
epitheloid cells |
|
|
|
|||||
Epstein-Barr virus |
230 |
|
|
|||||
ERM 39, 42, 43 |
|
|
|
|
|
|
||
ERM peeling |
40, 194 |
|
|
|
||||
erythematous systemic lupus (SLE) 193 |
|
|||||||
ethylene vinyl acetate (EVA) |
24 |
|
||||||
etoposide |
243 |
|
|
|
|
|
|
|
EVS Study |
245 |
|
|
|
|
|
|
|
excimer laser |
64 |
|
|
65 |
|
|
||
excimer laser ablation |
|
28 |
||||||
experimental autoimmune uveitis (EAU) |
||||||||
experimental PVR models 28 |
|
|||||||
external fistula |
214 |
|
|
|
|
|||
external leakage |
|
214 |
214 |
|
|
|||
external wound leakage |
|
|
||||||
extracellular matrix proteinases 193 |
|
|||||||
extracellular matrix proteins |
38 |
|
||||||
exudative retinal detachment |
54 |
|
||||||
eye wall resection |
229 |
|
|
|
||||
F |
|
|
|
|
36 |
|
|
|
Fas ligand (CD95L) |
|
|
||||||
feeder vessels |
194 |
|
|
|
|
|||
fibrin formation |
|
82, 104 |
|
|
||||
fibrin membrane |
130, 133 |
|
|
|||||
fibrinogen |
129 |
|
|
|
|
|
|
|
262 |
Subject Index |
|
fibrinous pupillary membranes 128 |
|
||
fibronectin |
129, 130, 137 |
|
|
fibrous vitreous band 203 |
|
||
filtering operation 116 |
|
||
filtering surgery |
151, 156 |
|
|
flare 69 |
95 |
|
|
flare meter |
|
|
|
Flieringa ring 256 |
|
||
flow cytometry |
231 |
|
|
fluconazol |
241 |
|
|
fluconazole |
29, 242 |
|
|
fluocinolone acetonide (Retisert™) implant |
8 |
||
fluocinolone acetonide depot (Retisert™) 14 |
18, 156 |
||
fluocinolone acetonide intravitreal implant |
|||
–characteristics 18
–efficacy 18
–patient selection 20
–safety 19
–surgical complications 20
–surgical procedure 20
fluocinolone acetonide intravitreal implants 51
fluorescein angiographic (FA) 192 |
|
||||
fluorescein angiography |
39, 40, 49, 50, 131, 132, 143, |
||||
194 |
|
|
192 |
|
|
fluorescein leakage |
|
|
|||
fluorophotometry |
122 |
|
|
||
fluorouracil |
28 |
|
|
|
|
flurbiprofen |
73 |
|
|
|
|
foldable hydrophobic acrylic lens 72 |
|
||||
foreign body giant cells |
109 |
76 |
|||
foreign body inflammatory response |
|||||
foreign body reaction 129, 130 |
|
||||
formalin |
250 |
|
|
|
|
foscarnet |
229, 243 |
|
193 |
|
|
frosted branch angiitis |
|
||||
Fuchs cyclitis |
94, 95 |
|
71, 82, 98 |
||
Fuchs heterochromic cyclitis (FHC) |
|||||
Fuchs heterochromic iridocyclitis (FHC) 67, 68, 70, 114, 115, 120, 128
Fuchs uveitis 143
Fuchs uveitis syndrome 41, 42, 135, 144
G
ganciclovir 29, 243 GDD surgery 156 giant cell reaction 129
giant cells |
120, 129 |
glaucoma |
48, 50, 68, 70, 81, 86, 87, 94, 123, 129, 141, |
144, 194 |
|
glaucoma drainage devices (GDD) 156, 157 |
|
gliosis 37 |
107 |
glistenings |
|
glycolide-co-lactide-co-caprolactone copolymer |
|
(PGLC) |
28 |
Goldmann–Witmer coefficient (GWc) 224, 243
Goldmann three-mirror lens |
48, 54 |
|
|
||||||
gonioprism |
116 |
|
|
|
|
|
|||
gonioscopy |
160, 214 |
|
|
|
|
||||
goniosynechiolysis |
117, 160 |
|
|
|
|
||||
goniotomy |
153, 178 |
|
|
|
|
||||
gout 63 |
|
|
|
|
|
|
|
|
|
H |
|
|
|
|
|
|
|
|
|
H-factor protein 193 |
|
|
|
|
|||||
haptics |
129 |
|
|
250 |
|
|
|
|
|
Heimann scissors |
|
|
|
|
|||||
hemorrhage |
42, 123, 192 |
|
|
|
|
||||
heparin |
76, 82, 206 |
|
|
|
137 |
||||
heparin surface-modified (HSM) PMMA IOLs |
|||||||||
herpes iridocyclitis |
143 |
|
|
|
|
||||
herpes simplex |
114, 115 |
|
221 |
|
|
||||
herpes simplex (HSV-1, HSV-2) |
241 |
|
|||||||
herpes simplex virus (HSV) types 1 and 2 |
|
||||||||
herpes simplex virus type 1 |
229 |
|
|
||||||
herpes zoster |
114, 115 |
|
|
|
|
||||
herpetic uveitis |
99 |
|
|
|
|
||||
heterochromia |
230 |
224 |
|
|
|||||
heterochromic iridocyclitis |
|
|
|||||||
high-frequency echography |
123 |
|
|
||||||
high IOP |
77 |
|
|
|
|
|
89, 208, |
||
highly active antiretroviral therapy (HAART) |
|||||||||
242 |
|
|
|
|
|
|
|
|
|
high molecular OVD 116 |
|
|
|
|
|||||
HLA-B27 |
70 |
|
|
114 |
|
|
|||
HLA B27-associated uveitis |
|
|
|||||||
HLA class I |
36 |
244, 246 |
|
|
|
|
|||
HOPE fixative |
|
|
|
|
|||||
Hoskins or a Ritch nylon suture lens 169 |
|
|
|||||||
HSV-2 |
230 |
|
|
|
|
246 |
|
|
|
HSV 1 and 2, VZV, CMV, EBV |
|
|
|||||||
HTLV-1-associated leukemia |
253 |
230 |
|
||||||
human herpes virus, designated HHV-8 |
|
||||||||
hyalocytes |
36, 38 |
|
|
|
|
|
|||
hyaluronan |
38 |
122 |
|
|
|
|
|||
hyaluronic acid |
|
|
|
|
|||||
hydrodissection |
134 |
|
|
|
|
||||
hypercalcemia |
63 |
|
|
|
|
|
|||
hypertension |
42 |
|
|
|
|
|
|||
hyphema |
71, 98, 123, 139, 143 |
|
|
|
|||||
hypopyon |
39, 239 |
|
|
|
|
|
|||
hypotension |
71 |
|
|
|
|
|
|||
hypotonous |
214 |
|
|
|
|
|
|||
hypotonous maculopathy 151 |
|
|
|
||||||
hypotony |
13, 42, 48, 68, 70, 71, 72, 82, 87, 115, 116, |
||||||||
123, 128, 134, 142, 160, 213 |
|
|
|
||||||
–hypotony maculopathy 13
–hypotony maculopathy secondary to chronic uveitis
associated with juvenile idiopathic arthritis 13 hypotony-maculopathy 213, 215
I
I-vation® 21
idiopathic arthritis-associated uveitis 70 idiopathic recurrent branch retinal arterial
occlusion |
193 |
|
|
|
|
||
idiopathic retinal vasculitis aneurysms |
|||||||
and neuroretinitis (IRVAN) |
193 |
||||||
IFN-α2a 230 |
|
|
|
|
|
||
IFNγ |
39 |
|
|
|
|
|
|
IL-10 |
36 |
|
37 |
|
|
|
|
IL-2 receptor |
|
|
|
|
|||
imipenem |
241 |
36, 37 |
|
||||
immune privilege |
|
||||||
immune recovery |
185 |
11 |
|
||||
immune recovery uveitis |
|
||||||
immune response |
221 |
228, 229, 231 |
|||||
immunohistochemistry |
|||||||
immunological tolerance |
35, 36 |
||||||
immunomodulation |
194 |
|
|||||
immunosuppression |
35, 40, 41, 43, 82, 127, 194 |
||||||
immunosuppressive and immunomodulatory |
|||||||
drugs |
35 |
|
|
|
|
186 |
|
immunosuppressive medication |
|||||||
immunosuppressives |
40 |
|
|
||||
immunosuppressive therapy 37, 88, 95
indirect ophthalmoscopy with scleral depression 202
infectious mononucleosis 230 |
|||
infliximab |
12 |
|
229 |
in situ hybridization |
|||
in situ PCR |
229 |
|
|
interferometry |
131 |
|
|
interleukin-10 |
253 |
70, 86, 115, 207, 214 |
|
intermediate uveitis |
|||
internal limiting membrane (ILM) 186 interstitial keratitis 115
intracapsular implantation |
120 |
|
intraepithelial dysplasia |
233 |
|
intraocular inflammation |
35 |
|
intraocular lens (IOL) |
86, 103, 119 |
|
intraocular lymphoma |
223, 238, 253 |
|
intraocular pressure (IOP) |
6, 7, 69, 149 |
|
intraoperative floppy-iris syndrome (IFIS) 97
intraretinal hemorrhages |
192 |
|||
intravenous pulse therapy |
82 |
|||
intravitreal methotrexate |
8 |
|||
intravitreal TA |
12 |
143, 186 |
||
intravitreal triamcinolone |
||||
invasive squamous cell carcinoma 233 |
||||
IOL |
129 |
137 |
|
|
IOL design |
|
|
||
IOLMaster |
132 |
|
|
|
IOP |
69 |
70, 115, 116, 117, 122, 142, 150, 151 |
||
iridectomy |
||||
iridocorneal angle 149 |
|
|||
iridocyclectomy |
231 |
|
||
Subject Index |
|
|
|
|
|
263 |
||||
iridocyclitis |
150 |
|
|
|
|
|
|
|||
iridotomy |
69, 70, 75, 97, 116, 117, 138, 139, 142 |
|||||||||
iris–lens synechiae |
94 |
|
|
|
|
|||||
iris atrophy |
67, 68, 70, 71, 94, 99 |
|
||||||||
iris bombé |
|
134, 142, 150 |
|
|
|
|||||
iris capture |
122, 134 |
|
|
|
|
|||||
iris hook |
|
75, 95, 96, 97, 138 |
|
|
||||||
iris neovascularization |
67 |
|
|
|||||||
iris nodule |
|
230 |
|
|
|
234 |
|
|||
iris nodule or granuloma |
|
|||||||||
iris prolapse |
97, 99 |
|
|
|
|
|
||||
iris spatula |
75 |
229 |
|
|
|
|
||||
iris tuberculoma |
|
|
|
|
||||||
ischemia |
|
50, 51 |
|
|
|
|
|
|
||
J |
70 |
|
|
|
|
|
|
|
|
|
JCA |
|
|
|
165 |
|
|
|
|
||
jeweler’s forceps |
|
|
|
|
||||||
JIA |
135, 144 |
|
|
|
115 |
|
||||
JIA-associated iridocyclitis |
|
|||||||||
JIA-associated uveitis |
130 |
|
|
|||||||
juvenile chronic arthritis |
68 |
|
86, 99, 114, 128, |
|||||||
juvenile idiopathic arthritis (JIA) |
||||||||||
139, 157 |
|
|
|
|
|
|
|
|
||
juvenile idiopathic arthritis (JIA) associated |
||||||||||
uveitis |
82, 120 |
|
|
|
|
|
||||
juvenile idiopathic arthritis associated iridocyclitis 67 |
||||||||||
juvenile rheumatoid arthritis |
214 |
230 |
||||||||
juvenile xanthogranuloma (JXG) |
||||||||||
K |
|
|
|
|
|
230 |
|
|
|
|
kaposi sarcoma (KS) |
|
|
|
|||||||
kaposi sarcoma herpes virus-associated uveitis 230 |
||||||||||
Kelly punch |
173 |
|
|
|
|
|
|
|||
keratectomy |
64 |
|
|
|
|
|
|
|||
keratitis |
229 |
|
|
|
|
|
|
|||
keratoplasty |
11 |
|
|
|
|
|
|
|||
– graft rejection |
11 |
|
|
|
|
|||||
Koeppe nodules |
70 |
|
|
|
|
|
||||
Koyanagi-Harada (VKH) syndrome 86 |
||||||||||
Krupin implants |
152 |
|
|
|
|
|||||
L |
|
137 |
|
|
|
|
|
|
||
laminin |
|
|
|
|
|
|
||||
LASEK |
64 |
|
|
65 |
|
|
|
|||
LASEK alcohol cup |
|
|
|
|||||||
laser |
194 |
|
|
|
|
|
|
95 |
|
|
laser flare meter photometry |
|
|||||||||
laser flare photometry |
131 |
|
|
|||||||
laser peripheral iridotomy |
150, 156 |
|||||||||
laser photocoagulation |
197 |
|
|
|||||||
laser retinopexy |
204 |
|
|
|
|
|||||
laser suture lysis |
165 |
|
|
|
|
|||||
LEC |
124, 137 |
|
|
|
|
|
|
|||
lens |
83 |
|
|
|
|
|
|
|
|
|
264 |
Subject Index |
|
lens-related uveitis |
115 |
|
|
||
lensectomy |
71, 85, 128, 134, 140, 195 |
|
|||
lens epithelial cell (LEC) |
120, 129 |
39 |
|||
Lens Opacity Classification System (LOCS) |
|||||
lepromatous uveitis |
229 |
|
|
||
leprosy 229 |
|
|
|
|
|
liposomes |
26, 29 |
|
|
38 |
|
log minimum angle of resolution (logMAR) |
|||||
Lucentis (ranibizumab) |
160 |
|
|||
Lyme disease |
81, 192, 229 |
|
|||
lytic cocktails |
142 |
|
|
|
|
M |
|
37, 120, 129 |
|
||
macrophages |
|
||||
macular atrophy 94
macular edema (ME) 7, 8, 39, 41, 42, 87, 94, 185, 186,
192, 194 |
|
42 |
|
|
|
macular holes |
94 |
|
|
||
macular ischemia |
|
|
|||
macular pucker |
144 |
|
50 |
||
magnetic resonance imaging |
|||||
MALT lymphoma |
231 |
|
|||
masquerade syndrome 38, 70, 223 |
|||||
Mediterranean spotted fever |
192 |
||||
membrane |
87 |
|
138 |
|
|
membranectomy |
|
||||
metalloproteinase |
193 |
|
|||
metaplasia |
104 |
|
|
|
|
methotrexate 51 |
|
41, 82, 83, 133, 194, 241 |
|||
methylprednisolone |
|||||
methylprednisolone acetate |
51 |
||||
microaneurysms |
192 |
|
|||
microbial culture |
223 |
|
|||
microincisional cataract surgery (MICS) 75 mini spatula 228
miosis 138, 139 miotics 122, 160 mitomycin 214
mitomycin C (MMC) 71, 151, 156 modern phacoemulsification 87 Molteno implant 71, 152 monocytes 120
mononuclear 36 mononuclear cells 35
mucosa-associated lymphoid tissue (MALT) 231 Müller glial cells 30
multifocal chorioretinitis 37, 40, 72
multifocal choroiditis 11, 12, 185, 186, 249, 253 multiple sclerosis 42, 50, 192
MVR blade 88
mycophenolate mofetil (MMF) 41 mydriatics 122
myofibroblasts 121, 141
N |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nd:YAG/argon laser iridotomy 116 |
|
|
|||||||||||
Nd:YAG goniosynechiolysis |
152 |
|
|
|
|||||||||
Nd:YAG laser |
|
54, 69 |
|
|
89 |
|
|
|
|||||
Nd:YAG laser capsulotomy |
|
|
|
||||||||||
Nd:YAG laser iridotomy |
|
69, 122 |
|
|
|
||||||||
Nd:YAG laser vitreolysis |
160 |
241 |
|
|
|||||||||
necrotizing viral retinopathies |
|
|
|||||||||||
neovascularization |
10, 39, 47, 49, 50, 51, 68, 70, 141, |
||||||||||||
193, 194 |
|
|
|
|
|
|
|
|
|
|
|
|
|
– of the iris |
10 |
|
|
|
|
|
|
|
|
|
|||
neovascularization of retinal vessels 130 |
|||||||||||||
neuropeptide |
36 |
|
|
193 |
|
|
|
|
|
||||
nitric oxide synthetase |
|
|
|
|
|
||||||||
non-Hodgkin lymphoma |
244 |
151 |
|
||||||||||
nonpenetrating glaucoma surgery |
|
||||||||||||
nonsteroidal anti-inflammatory drug |
82 |
||||||||||||
Norrie disease |
63 |
|
|
|
|
|
|
|
|
|
|||
NSAID |
73, 77, 78 |
|
|
229 |
|
|
|
|
|
||||
nucleotide sequencing |
|
|
|
|
|
||||||||
O |
|
|
|
|
130, 131, 143 |
|
|
|
|||||
occlusion therapy |
192 |
|
|||||||||||
occlusive retinal vasculitis (ORV) |
|
||||||||||||
OCT 42, 186 |
|
|
|
94 |
|
|
|
|
|
|
|||
ocular hypertension |
|
|
|
|
|
24 |
|||||||
ocular implantable drug delivery system |
|||||||||||||
ocular posttransplant lymphoproliferative |
|||||||||||||
disorder |
229 |
|
|
|
|
|
|
233 |
|
||||
ocular surface squamous neoplasia |
|
||||||||||||
oculocerebral lymphoma |
244 |
|
|
|
|||||||||
oligo(deoxy)nucleotides |
|
30 |
|
|
|
|
114 |
||||||
ophthalmic viscoelastic devices (OVD) |
|||||||||||||
optical coherence tomography (OCT) |
39, 50, 94, 143, |
||||||||||||
192 |
|
|
|
|
|
|
|
|
|
131 |
|
|
|
optical coherent tomography |
|
|
|
||||||||||
optic atrophy |
72 |
|
|
|
|
|
|
|
|
|
|||
opticin |
38 |
|
|
|
94 |
|
|
|
|
|
|
|
|
optic neuropathy |
|
|
|
|
|
|
|
|
|||||
oral steroids |
42 |
|
|
|
|
|
|
|
|
|
|||
orbital cellulitis |
230 |
|
|
|
|
|
|
|
|
||||
orbital lymphoma |
231 |
|
|
|
|
|
|
|
|||||
outcome of cataract surgery by phacoemulsification |
|||||||||||||
in Fuchs heterochromic cyclitis |
99 |
|
|
||||||||||
P |
|
|
63 |
|
|
|
|
|
|
|
|
|
|
Paget disease |
|
|
|
|
|
160, 194 |
|
|
|||||
panretinal photocoagulation |
|
|
|
||||||||||
paracentheses |
|
95 |
|
|
|
|
|
|
|
|
|
||
paracetamol |
65 |
|
|
|
|
|
|
|
|
|
|||
pars plana |
38 |
|
|
47, 48 |
|
|
|
|
|
||||
pars plana exudates |
|
39, 185, 205, 240 |
|||||||||||
pars plana vitrectomy (PPV) |
|
||||||||||||
pars planitis (PP) 42, 48, 49, 67, 70, 77, 192
pars planitis syndrome |
70 |
|
|
|
||||||
particulate drug delivery system 26 |
|
|||||||||
patch graft |
167 |
|
|
|
|
|
|
|||
patient |
72 |
|
|
|
|
|
|
|
|
|
PCO |
124, 130, 137, 141 |
|
|
|
||||||
PCR |
223, 224, 227, 229, 246 |
|
|
|
||||||
PDDS |
|
28 |
|
|
103 |
|
|
|
|
|
pediatric cataract |
|
|
|
|
||||||
pediatric glaucoma |
176, 178 |
|
|
|
||||||
PEGylation |
26 |
|
|
|
250 |
|
||||
perfluorocarbon liquid (PFCL) |
|
|||||||||
periocular corticosteroid injection |
5 |
95 |
||||||||
period of quiescence before surgery |
|
|||||||||
perioperative immunosuppression |
41 |
|||||||||
peripheral anterior synechiae |
150, 160 |
|||||||||
peripheral iridectomy |
156 |
|
|
|
||||||
peripheral iridoplasty |
156 |
|
|
|
||||||
peripheral iridotomy |
|
99, 156 |
|
|
|
|||||
PFCL |
250 |
|
|
|
|
|
|
|
|
|
phacoanaphylactic uveitis 120 |
|
|
||||||||
phacoantigenic uveitis |
130, 131 |
|
|
|||||||
phacoemulsification |
85, 86, 93, 128, 140, 195 |
|||||||||
phacoemulsification machine |
96 |
|
|
|||||||
phimosis 141 |
|
|
|
|
|
|
64, 65, 138 |
|||
phototherapeutic keratectomy (PTK) |
||||||||||
phthisical eye |
115 |
|
|
|
|
|
||||
phthisis |
42, 87, 123, 134, 142, 144 |
|
|
|||||||
phthisis bulbi |
48, 50, 68, 72, 86, 152 |
|
||||||||
pigment deposit |
70 |
|
|
|
|
|
||||
pilocarpine |
160 |
|
|
|
|
|
|
|||
PLA |
28 |
221 |
|
|
|
|
|
|
||
plasma cell |
|
|
|
38 |
|
|
||||
platelet-derived growth factor |
|
|
||||||||
PLGA |
|
27, 28 |
|
|
|
204 |
|
|
|
|
pneumatic retinopexy |
|
|
|
|||||||
POE |
27 |
|
|
|
|
|
|
|
24 |
|
poly(lactic-co-glycolic acid) (PLGA) |
||||||||||
polyanhydrides |
|
25 |
|
|
|
|
|
|||
–1,3-bis(carboxyphenoxypropane) (PCPP) 25
–sebatic acid (SA) 25
polyarteritis nodosa 192, 193 polycaprolactone (PCL) 25, 28
– porous reservoir 25 polyfluorocarbon (Teflon) 105 polylactic acid (PLA) 24 polymer 24
– Complications associated with the implantation 24
polymerase chain reaction (PCR) |
224, 240, 243 |
polymethylmethacrylate (PMMA) |
103, 104 |
polymethyl methacrylate (PMMA) pupil dilator ring 96
polymorphonuclear leukocyte (PMN) 129 Polyvinyl alcohol (PVA) 24 Posner–Schlossman iridocyclitis 69
Subject Index |
|
|
|
|
|
|
|
265 |
|||
Posner-Schlossman syndrome |
70 |
|
|
||||||||
posterior capsular opacification |
71 |
|
|
||||||||
posterior capsular rupture |
94 |
|
27, 75, 77, 89, |
||||||||
posterior capsule opacification (PCO) |
|||||||||||
90, 103, 120, 121, 129, 140 |
|
|
|
||||||||
posterior capsule opacity 195 |
|
|
|
||||||||
posterior capsulorhexis |
128 |
|
|
|
|||||||
posterior capsulotomy |
99 |
|
|
|
|
||||||
posterior hyaloid |
88 |
|
195 |
|
|
|
|||||
posterior hyaloid removal |
|
|
|
||||||||
posterior scleritis |
150 |
|
|
|
9, 70 |
|
|||||
posterior subcapsular cataract (PSC) |
|
||||||||||
posterior synechiae |
87, 128, 138, 139 |
38, 41, 48, 186, |
|||||||||
posterior vitreous detachment (PVD) |
|||||||||||
193 |
|
|
|
|
|
|
|
|
158 |
|
|
postoperative fibrin formation |
|
|
|||||||||
postoperative hypertension |
123 |
|
|
||||||||
postoperative PVR |
|
206 |
|
|
|
|
|
||||
Posurdex™ |
14, 18, 21 |
|
|
|
72 |
|
|||||
potential acuity measurement (PAM) |
|
||||||||||
povidone-iodine |
8 |
|
|
|
|
|
|
||||
PPV |
40, 143 |
41, 78, 82, 83, 96 |
|
|
|
||||||
prednisolone |
|
|
|
||||||||
prednisolone acetate |
5 |
73, 82 |
|
|
|||||||
prednisolone acetate 1% |
|
|
|||||||||
prednisolone succinate |
82 |
|
|
|
|
||||||
prednisone |
73 |
|
|
|
|
|
|
|
|
||
prephthisical |
214 |
|
|
|
|
|
|
|
|||
presumed ocular histoplasmosis syndrome |
|
||||||||||
(POHS) |
12 |
|
|
|
|
|
|
|
|
||
primary central nervous system lymphoma |
|
||||||||||
(PCNSL) |
244 |
|
|
|
|
232 |
|
|
|||
primary intraocular lymphoma |
|
|
|||||||||
primary intraocular lymphoma (PIOL) 244, 249 |
|||||||||||
primary posterior capsulorhexis (PPCCC) |
122, 141 |
||||||||||
progressive outer retinal necrosis (PORN) |
241 |
||||||||||
prolene haptics |
76 |
|
|
|
|
10, 27, 29, 37, |
|||||
proliferative vitreoretinopathy (PVR) |
|||||||||||
90 |
|
|
|
|
|
|
|
|
|
|
|
prostaglandin analogs 69 |
|
|
|
|
|||||||
prostaglandins |
7 |
|
|
104 |
|
|
|
||||
prostaglandin synthesis |
|
95 |
|
||||||||
protein levels in the anterior chamber |
|
||||||||||
pseudoendophthalmitis |
8 |
|
|
|
|
||||||
pseudohypopyon |
8 |
|
|
|
|
|
|
||||
psoriatic arthritis |
214 |
|
|
|
|
|
|||||
pupillary block |
116, 142, 150 |
|
|
|
|||||||
pupillary membrane |
69, 86, 138, 144 |
|
|
||||||||
pupillary seclusion |
|
69 |
|
|
|
|
|
||||
pupil size |
130 |
96 |
|
|
|
|
|
|
|||
pupil stretching |
|
|
|
|
|
|
|||||
PVA–EVA |
28 |
|
|
|
|
|
|
|
|
||
PVR |
42, 214 |
|
|
|
|
|
|
|
|
|
|
266 |
Subject Index |
|
Q
questionnaire 81
R
“Rip Cord” technique 164
recombinant tissue plasminogen activator (rt-PA) 28,
69, 83 |
|
|
|
|
214 |
|
|
|
|
Reiter’s syndrome |
|
|
|
|
|||||
renal failure 63 |
|
52 |
|
|
|
|
|||
retinal cryotherapy |
|
|
|
|
|||||
retinal detachment |
9, 48, 50, 68, 70, 89, 123, 130, 135, |
||||||||
150, 192, 195, 202, 203 |
|
|
|
||||||
retinal ischemia |
192 |
|
|
54 |
|
||||
retinal laser photocoagulation |
|
||||||||
retinal pigment epithelium (ARPE-19) cells 9 |
|||||||||
retinal pigment epithelium (RPE) |
36 |
||||||||
retinal vasculitis (RV) |
191, 192, 229 |
||||||||
retinitis-pigmentosa-like changes |
50 |
||||||||
retinopathy |
238 |
|
|
|
|
|
|||
retinoschisis |
54 |
|
|
|
|
|
|||
retinotomy |
250 |
|
|
|
|
|
|
||
Retisert® |
18, 156, 215 |
|
99 |
|
|
||||
retroillumination of the iris |
|
|
|||||||
Roth spots |
239 |
|
|
|
|
|
|
||
RPE 36, 37 |
144 |
|
|
|
|
|
|||
RPE atrophy |
|
|
|
|
|
||||
rubeosis |
123, 143 |
|
|
|
|
|
|||
rubeosis iridis |
71, 194 |
|
|
97 |
|||||
rupture of the posterior capsule |
|||||||||
S |
|
12, 37, 42, 70, 71, 81, 82, 114, 115, 135, |
|||||||
sarcoidosis |
|||||||||
186, 192, 193, 214, 233, 249, 253 |
|
||||||||
Sato knife |
141 |
|
|
|
|
94 |
|||
scanning laser ophthalmoscope |
|||||||||
scleral buckling procedures |
195 |
|
|||||||
scleral buckling surgery |
204 |
|
|
|
|||||
scleral buckling versus primary vitrectomy |
|||||||||
in rhegmatogenous retinal detachment study |
|||||||||
(SPR study) |
205 |
|
|
|
|
||||
scleral depression |
88 |
|
|
|
|
||||
scleral grafting |
229 |
|
|
|
|
||||
scleral nodule |
228 |
|
|
|
|
|
|||
scleral trocar |
195 |
|
|
|
|
|
|||
scleritis |
228, 232 |
|
|
|
|
|
|||
scleromalacia |
228 |
|
|
|
|
|
|||
SCORE (Standard of Care versus Corticosteroids |
|||||||||
for Retinal Vein Occlusion) |
6 |
|
|||||||
SCORE study |
8 |
|
|
|
|
|
|||
scotomata |
192 |
|
|
|
|
|
|
||
secondary glaucoma 132 |
|
|
|
||||||
secondary implant |
109 |
|
|
|
|||||
sector iridectomy |
228 |
|
|
|
|
||||
Seidel test |
168 |
|
|
|
|
|
|
||
serous macular detachment |
142 |
|
||||||||
serpiginous choroiditis |
12 |
|
|
|
||||||
setons |
152 |
|
|
107 |
|
|
|
|
||
sharp optic edges |
|
|
|
|
||||||
sheathing |
70, 192 |
|
|
|
|
|
|
|||
shrinkage |
141 |
|
|
|
|
|
|
|
||
shunt vessels |
194 |
|
|
|
|
|
|
|||
silicone IOLs |
137 |
|
|
|
|
|
|
|||
silicone oil |
213, 250 |
|
89 |
|
|
|
||||
silicone oil tamponade |
|
|
|
|||||||
Sinskey hook |
96 |
|
|
|
|
|
|
|||
sirolimus |
28 |
|
|
|
|
|
|
|
116 |
|
smooth-tipped irrigating cyclodialysis spatula |
||||||||||
snowball |
42, 48, 70 |
|
|
|
|
|
||||
snowbank |
48, 70 |
|
|
|
|
|
|
|||
snowbanking |
42, 48 |
|
|
|
|
107 |
||||
snowflake-like opacification in the lens optic |
||||||||||
snowflake degeneration |
107 |
|
|
|||||||
Standardization of Uveitis Nomenclature (SUN) |
||||||||||
working group |
39 |
|
|
|
|
|||||
steroid |
42, 77, 143 |
|
|
|
|
|
||||
steroid responders |
8 |
163 |
|
|
|
|||||
Stevens muscle hooks |
163 |
|
||||||||
Stevens tenotomy scissors |
|
|||||||||
Still disease 63 |
|
|
|
|
|
|
|
|||
strabismus |
144 |
|
|
|
|
|
|
|
||
streptokinase |
69 |
|
186 |
|
|
|
||||
submacular surgery |
|
|
|
|||||||
subretinal space |
28, 254 |
|
|
|
||||||
subretinal surgery |
249 |
|
|
|
|
|||||
Super Quad 160 lens |
54 |
|
156 |
|
||||||
surgical peripheral iridectomy |
|
|||||||||
sustained-release dexamethasone implant 14 |
|
|||||||||
sympathetic ophthalmia |
12, 36, 37, 138, 151, 152 |
|||||||||
– intravitreal TA |
12 |
|
|
|
|
|||||
synechiae |
67, 68, 69, 70, 82, 95, 122, 142, 144 |
|
||||||||
synechiolysis |
116, 122 |
|
|
|
|
|||||
syphilis |
69, 114, 115 |
|
82 |
|
|
|
||||
systemic corticosteroid |
|
192 |
|
|||||||
systemic erythematous lupus |
|
|||||||||
systemic lupus erythematosis |
214 |
|
||||||||
T |
|
|
|
151 |
|
|
|
|
|
|
T-flux implant |
|
|
|
|
|
|
||||
T-lymphocytes |
35, 36, 37, 38, 39 |
|
||||||||
tamoxifen |
28 |
|
|
|
97 |
|
|
|
||
tamsulosin (Flomax) |
|
|
|
|||||||
tarsorrhaphy |
168 |
|
|
|
|
|
|
|||
telangiectasia |
192 |
|
|
|
|
|
|
|||
TGFb2 |
30 |
|
|
|
|
|
|
|
|
|
TGFβ |
36 |
|
|
|
37 |
|
|
|
|
|
thrombospondin 1 |
|
|
|
|
||||||
thymidine kinase |
229 |
|
|
|
|
|||||
tissue plasminogen |
122 |
|
|
|
||||||
tissue plasminogen activator (TPA) 142, 173
TNF-α |
30, 37 |
|
36 |
|
|
|
|||
tolerance induction |
|
|
|
||||||
topical corticosteroid |
|
78 |
|
82 |
|||||
topical corticosteroid eyedrops |
|||||||||
topical steroid |
41 |
|
|
243 |
|
||||
topoisomerase II inhibitor |
|
||||||||
Touton giant cell |
231 |
|
|
12 |
|
||||
toxoplasmic retinochoroiditis |
|
||||||||
– intravitreal dexamethasone in combination |
|||||||||
with intravitreal clindamycin 12 |
|||||||||
toxoplasmosis |
52, 81, 99, 192, 214 |
|
|||||||
trabecular meshwork (TM) |
116 |
|
|||||||
trabeculectomy |
70, 71, 151, 156, 178, 228 |
||||||||
trabeculodialysis |
70 |
|
|
54 |
|
||||
traction retinal detachment |
|
||||||||
transforming growth factor β (TGFβ) 36 |
|||||||||
transpupillary |
87 |
|
|
|
|
|
|||
trephine |
228 |
28, 43, 88, 97, 122, 123, 140, 142, 143 |
|||||||
triamcinolone |
|||||||||
triamcinolone acetonide (TA) |
6, 41, 51, 82, 96, 97, |
||||||||
133, 140 |
|
|
|
|
|
|
|
|
|
– preservative-free formulations |
8 |
||||||||
trypan blue staining |
99 |
|
|
|
|||||
tube extender |
167 |
|
|
|
|
|
|||
tube inserter |
|
167 |
|
|
|
|
|
||
tuberculosis |
69, 81, 114, 115, 192, 229, 253 |
||||||||
Tutoplast 167 |
|
|
104 |
|
|
|
|||
Tyndall phenomenon |
|
|
|
|
|||||
U |
|
|
|
|
|
|
|
|
214 |
UBM (ultrasonic biomicroscopy) |
|||||||||
UGH syndrome |
115 |
|
|
|
214 |
||||
ultrasonic biomicroscope (UBM) |
|||||||||
ultrasonography |
131 |
|
|
|
|
||||
ultrasound |
131, 213 |
|
|
|
|
115, 150 |
|||
ultrasound biomicroscopy (UBM) |
|||||||||
useful vision |
|
159 |
|
130 |
|
|
|
||
uveal biocompatibility |
|
|
|
||||||
uveal effusion |
130, 142, 150 |
|
|
||||||
uveal response 120 |
|
186 |
|
|
|||||
uveitic macular disease |
186 |
||||||||
uveitic macular edema (UME) |
|||||||||
uveitis |
38, 70, 229 |
|
|
|
|
|
|||
uveitis, glaucoma, and hyphema (UGH) |
|||||||||
syndrome |
137 |
|
|
|
|
|
|||
uveitis-glaucoma-hyphema (UGH) syndrome 114
V
valacyclovir 99 Valganciclovir 243
Subject Index |
|
|
|
267 |
|||
valves |
152 |
240, 241 |
|
|
|||
vancomycin |
|
|
|||||
– intravitreal vancomycin 13 |
|||||||
Vannas scissors |
75, 115, 117, 165, 228 |
||||||
varicella zoster |
221 |
|
241 |
||||
varicella zoster virus (VZV) |
|||||||
vascular endothelial growth factor (VEGF-A) 193 |
|||||||
vasculitis |
39, 42, 70, 143 |
|
|||||
VEGF |
7 |
|
|
117 |
|
|
|
viscodissection |
|
|
|||||
viscoelastics |
75 |
|
|
95 |
|
||
viscoelastic substance |
|
||||||
visual acuity (VA) |
38, 41, 130, 192 |
||||||
visual deprivation amblyopia |
130 |
||||||
visual field |
132 |
|
|
|
|
||
visual rehabilitation 128 |
|
||||||
Vitrasert |
29 |
|
|
|
|
|
|
vitrectomy |
35, 56, 85, 88, 138, 194, 195, 197 |
||||||
vitrectomy probe |
75 |
|
|
||||
vitreomacular traction (VMT) 186, 187 |
|||||||
vitreoretinal adhesion |
47 |
|
|||||
vitreoretinal endoscope 213 |
|
||||||
vitreoretinal traction |
192 |
|
|||||
vitreous body |
38 |
|
|
|
|||
vitreous haze |
39, 70 |
9, 42, 49, 50, 68, 70, 135, 192, |
|||||
vitreous hemorrhage |
|||||||
194 |
|
|
|
|
40 |
|
|
vitreous infiltrates |
|
|
|||||
vitreous opacity |
41, 94, 98, 130, 135 |
||||||
vitreous specimens |
246 |
|
|||||
vitreous tap |
240, 245 |
|
|
||||
vitritis |
48 |
|
72 |
|
|
||
VKH syndrome |
|
|
|||||
Vogt-Koyanagi-Harada (VKH) syndrome 12, 150 |
|||||||
– intravitreal TA |
12 |
|
|
||||
Vogt-Koyanagi-Harada disease (VKH) 37, 214
W
warfarin (Coumadin), 160 Wegener’s granulomatosis 193 Weiss rings 187
Westcott scissors 163, 165 white dot syndrome 37
Y
YAG laser 142
yttrium aluminum garnet (YAG) laser 117
Z
zonular dialysis 98
